Clinitech Laboratory Complete Financial Statements
In FYNone, Clinitech Laboratory (CTLLAB) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00. Full financial statements from FY2025 to FY2026 (2 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see CTLLAB share price.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
CTLLAB Revenue, Net Profit & EBITDA — Year-on-Year Growth
CTLLAB YoY (March 2026 vs Period) — revenue -100.0%, EBITDA -100.0%, expenses -100.0%. Compare with CTLLAB fair price to assess whether the stock is under or overvalued.
CTLLAB Income Statement — Revenue, EBITDA & Net Profit
Clinitech Laboratory revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (None).
| Particulars | None | March 2026 | March 2025 |
|---|---|---|---|
| Revenue | 0 | 10 | 9 |
| Expenses | 0 | 9 | 7 |
| EBITDA | 0 | 1 | 1 |
| Operating Profit Margin % | 0.00% | 10.00% | 10.00% |
| Depreciation | 0 | 1 | 0 |
| Interest | 0 | 0 | 0 |
| Profit Before Tax | 0 | 1 | 1 |
| Tax | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 |
| Earnings Per Share (₹) | 0.00 | 1.83 | 1.90 |
CTLLAB Balance Sheet — Assets, Liabilities & Shareholders' Equity
CTLLAB total assets ₹11 Cr, total equity ₹9 Cr, total liabilities ₹ Cr (2026).
| Particulars | 2026 | 2025 |
|---|---|---|
| ASSETS | ||
| Total Assets | 11 | 11 |
| Current Assets | 7 | 8 |
| Fixed Assets | 2 | 2 |
| Capital Work in Progress | 1 | 1 |
| Investments | 0 | 0 |
| Other Assets | 8 | 8 |
| LIABILITIES | ||
| Total Liabilities | ||
| Current Liabilities | 1 | 0 |
| Non-Current Liabilities | ||
| SHAREHOLDERS' EQUITY | ||
| Total Equity | 9 | 9 |
| Share Capital | 2 | 2 |
| Reserves & Surplus | 7 | 7 |
CTLLAB Cash Flow Statement — Operating, Investing & Financing
Clinitech Laboratory operating cash flow ₹-1 Cr, investing ₹-1 Cr, financing ₹1 Cr, net cash flow ₹-1 Cr (2026).
| Particulars | March 2026 | March 2025 |
|---|---|---|
| Operating Activities | -1 | -1 |
| Investing Activities | -1 | -1 |
| Financing Activities | 1 | 4 |
| Net Cash Flow | -1 | 2 |